ClinConnect ClinConnect Logo
Search / Trial NCT06880159

Transcranial Direct Current Stimulation in Children with Autism Spectrum Disorder

Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Mar 11, 2025

Trial Information

Current as of April 30, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called Transcranial Direct Current Stimulation (tDCS) for children with Autism Spectrum Disorder (ASD). tDCS is a safe method that uses a gentle electrical current to stimulate specific parts of the brain, and it may help improve thinking and behavior in children with ASD. In this trial, researchers will look at how effective tDCS is when combined with cognitive training exercises over ten consecutive days. They will compare the results of children receiving the actual tDCS treatment to those receiving a "sham" (fake) treatment to see if it really makes a difference.

To participate in the study, children must be between 8 and 12 years old, have a diagnosis of ASD, and be able to communicate in Chinese. They should also have an IQ above 60. Children with serious motor difficulties or a history of other neurological or psychiatric issues will not be eligible. Participants will receive 20-minute sessions of tDCS along with cognitive training and will undergo some tests before and after the treatment to measure any changes. This study aims to better understand how tDCS affects cognitive skills and the brain's function in children with ASD, which could help in developing future treatments.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • being 8-12 years old
  • diagnosed with ASD given by registered psychiatrists or clinical psychologists according to the Diagnostic and Statistical Manual of Mental Disorders-5th Edition (DSM-5) criteria of ASD
  • IQ score above 60
  • able to communicate in Chinese
  • Exclusion Criteria:
  • with severe motor dysfunctions
  • history of other neurological and psychiatric disorders or head trauma

About The Hong Kong Polytechnic University

The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.

Locations

Hung Hom, Kowloon, Hong Kong

Patients applied

0 patients applied

Trial Officials

Yvonne Han, PhD

Principal Investigator

The Hong Kong Polytechnic University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported